Bone Therapeutics


Bone Therapeutics has developed two first-in-class products, PREOB® and ALLOB®, which target 6 indications in clinical trials and offer the potential for additional product extensions.

In addition, Bone Therapeutics is conducting preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications or enhanced viscosupplementation for osteoarthritis.